A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2004
12/28/2004	US6835389 Powder Composition for nasal administration
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	US6835326 For ink jet imaging/anticounterfeiting; semiconductors
12/28/2004	US6835194 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
12/28/2004	US6835015 Jelly pens
12/28/2004	CA2287534C Biodegradable microparticles for the sustained delivery of therapeutic drugs
12/28/2004	CA2240329C Improved delivery of multiple doses of medications
12/28/2004	CA2128103C Formulation and use of carotenoids in treatment of cancer
12/28/2004	CA2120709C Enzyme-orthokeratology
12/23/2004	WO2004111194A2 Method to increase protein production in culture
12/23/2004	WO2004111185A2 Direct micro-patterning of lipid bilayers using uv light and selected uses thereof
12/23/2004	WO2004110603A2 Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions
12/23/2004	WO2004110585A1 Radial spherical crystallization product, process for producing the same and dry powder preparation containing the crystallization product
12/23/2004	WO2004110539A1 Administration of medicinal dry powders
12/23/2004	WO2004110520A2 Improved system and method for facilitating hemostatis with an absorbable sponge
12/23/2004	WO2004110497A2 Mitomycin conjugates cleavable by thiols
12/23/2004	WO2004110495A1 Compositions for oral administration of campothecin and its analogs
12/23/2004	WO2004110494A1 Compositions for treating infection in cattle and swine
12/23/2004	WO2004110493A2 Method of pulmonary administration of an agent
12/23/2004	WO2004110491A1 Combined doses
12/23/2004	WO2004110486A1 Functionally reconstituted viral membranes containing adjuvant
12/23/2004	WO2004110480A2 Polyanionic polymer adjuvants for haemophilus influenza b saccharide vaccines
12/23/2004	WO2004110468A1 Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
12/23/2004	WO2004110448A1 Medicinal composition containing benidipine hydrochloride
12/23/2004	WO2004110445A1 Phentanyl-containing adhesive patch for application to oral-cavity mucosa
12/23/2004	WO2004110431A1 Stable compositions of atorvastatin prepared with wet granulation
12/23/2004	WO2004110428A1 Anti-inflammatory analgesic adhesive patch
12/23/2004	WO2004110422A1 Extended-release tablets of metformin
12/23/2004	WO2004110413A1 A composition for an enteric coating of natural product containing lectin
12/23/2004	WO2004110412A1 Microcapsules for the administration of active ingredients
12/23/2004	WO2004110411A2 Orally-dispersible multilayer tablet
12/23/2004	WO2004110410A1 Extended release composition containing tramadol
12/23/2004	WO2004110409A1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation
12/23/2004	WO2004110408A2 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
12/23/2004	WO2004110407A1 Process for forming amorphous atorvastatin
12/23/2004	WO2004110406A1 Pharmaceutical compositions of atorvastatin
12/23/2004	WO2004110405A1 Drug nano-particle, method and apparatus for preparing pharmaceutical preparation using the particle
12/23/2004	WO2004110404A1 Combined doses of tiotropium and fluticasone
12/23/2004	WO2004110403A1 Transnasal microemulsions containing diazepam
12/23/2004	WO2004110402A1 Oil emulsion for postnatal hormone substitution
12/23/2004	WO2004110401A2 Inhalation antiviral patch
12/23/2004	WO2004110400A2 Implantable polymeric device for sustained release of nalmefene
12/23/2004	WO2004110398A1 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
12/23/2004	WO2004110381A2 Pharmaceutical compositions comprising active vitamin d compounds
12/23/2004	WO2004110380A2 Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents
12/23/2004	WO2004110346A2 Sustained release of antiinfectives
12/23/2004	WO2004110323A1 Dressing
12/23/2004	WO2004110151A1 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
12/23/2004	WO2004098566A3 Chewable lozenge cold remedy composition and method for making same
12/23/2004	WO2004098503A3 Drug releasing biodegradable fiber for delivery of therapeutics
12/23/2004	WO2004096181A3 Solid dosage form comprising desmopressin
12/23/2004	WO2004096125A3 Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem
12/23/2004	WO2004087204A3 Microfluidized oil-in-water emulsions and vaccine compositions
12/23/2004	WO2004087203A3 Immunostimulatory nucleic acid oil-in-water formulations for topical application
12/23/2004	WO2004087121A3 Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases
12/23/2004	WO2004078142A3 Compositions and methods for preventing and treating endotoxin-related diseases and conditions
12/23/2004	WO2004069141B1 Transdermal granisetron
12/23/2004	WO2004069032A3 Viscous swallow medium and method of use for esophageal function testing
12/23/2004	WO2004054541A3 Ketoprofen compositions and methods of making them
12/23/2004	WO2004049095A3 Betaine and salicylic acid compositions
12/23/2004	WO2004036186A3 Microencapsulation and sustained release of biologically active polypeptides
12/23/2004	WO2003097805A3 Delivery of nucleic acid-like compounds
12/23/2004	WO2003089002A9 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
12/23/2004	WO2003000237A8 Biodegradable polymer coompositions
12/23/2004	US20040260391 Stent for controlled release of drug
12/23/2004	US20040260272 Method and system for intravesicular delivery of therapeutic agents
12/23/2004	US20040260233 Data collection assembly for patient infusion system
12/23/2004	US20040259956 Adimistering analgesics by titration for dosage using tramadol and kits
12/23/2004	US20040259954 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy
12/23/2004	US20040259952 Formulations for oral administration of cromolyn sodium
12/23/2004	US20040259941 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
12/23/2004	US20040259905 stable, less irritant and easily administrable; high concentration of sulfodehydroabietic acid or salt ion at pH of 7-8.5 in a buffer of a polyphosphate salt or polycarboxylic acid salt such as trisodium citrate and an inorganic base such as sodium hydroxide; for inflammatory bowel disease treatment
12/23/2004	US20040259899 in patients who are refractory to laxative and stool softener treatment, such as cancer patients on opioids such as morphine, using an opioid antagonist such as methylnaltrexone and a laxative and/or stool softener
12/23/2004	US20040259895 Oral formulation of lipid soluble thiamine and lipoic acid
12/23/2004	US20040259844 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage
12/23/2004	US20040259841 Low molecular weight; nutritional supplement; softening of human skin;orally administering
12/23/2004	US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis
12/23/2004	US20040259837 Modification of solid 3-sn-phosphoglycerides
12/23/2004	US20040259835 Stabilized brivudine topical formulations
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259796 Using a peptide
12/23/2004	US20040259788 Use of neurotoxin therapy for treatment of urologic and related disorders
12/23/2004	US20040259248 RNA interference mediating small RNA molecules
12/23/2004	US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference)
12/23/2004	US20040259245 Complete nutrient medium for use as a cosmetic and cosmetic use thereof
12/23/2004	US20040259218 Wood adhesives containing solid residues of biomass fermentations
12/23/2004	US20040258896 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
12/23/2004	US20040258783 Cosmetic composition comprising an essential oil extracted from Helichrysum italicum
12/23/2004	US20040258774 Manual clitoral sensitizing mixture having a cooling agent chosen from oils of peppermint, cornmint, eucalyptus, camphor, citronella and cinnamon
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258769 Use of ocular vitamins in conjunction with other treatment methods for AMD
12/23/2004	US20040258764 Polysaccharide comprising xanthan gum, alginate, starch, carrageenan and natural gums; surfactant, cosolvent, and diluent; micelle in colloid suspension; plant growth regulators; decreasing fungus and insect infestation
12/23/2004	US20040258763 Methods of manufacture and use of calcium phosphate particles containing allergens
12/23/2004	US20040258762 Microparticle of crosslinked protein shell with amine, hydroxyl, carboxylate and/or sulfhydryl moitey covalently bonded to surface coating of polyoxyethylene glycol
12/23/2004	US20040258758 Stabilizer adsorped on particle surface; adhere to gut increasing time for absorption, and effectiveness; low dosage; antiepileptic, anxiolytic and antidepressant agents; post traumatic stress syndrome bipolar and psychological disorders; schizophrenia
12/23/2004	US20040258757 Liquid dosage compositions of stable nanoparticulate active agents
12/23/2004	US20040258756 Novel process
12/23/2004	US20040258755 Dissolved cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(alkanoyloxy)]platinum(II) in 2-methyl-2-propanol; stabile, easily handled injection; fine, homogenous suspension; controlled particle size distribution
12/23/2004	US20040258754 Compositions for oral administration of camptothecin and its analogs

1 ... 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 ... 2991